Alcoholic cardiomyopathy

Journal of Cardiovascular Medicine

Volumn 11, Issue 12, 2010, Pages 884-892

  Iacovoni, Attilio ^a   De Maria, Renata ^b   Gavazzi, Antonello ^a  

^a OSPEDALI RIUNITI   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

alcoholic; cardiomyopathy; heart failure

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VERAPAMIL;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLIC CARDIOMYOPATHY; APOPTOSIS; CELL DAMAGE; CONGESTIVE CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; HEART LEFT VENTRICLE HYPERTROPHY; INCIDENCE; MORBIDITY; MORTALITY; MUSCLE CELL; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; SEX DIFFERENCE; SYSTOLIC DYSFUNCTION;

ALCOHOL DRINKING; ANIMALS; CARDIOMYOPATHY, ALCOHOLIC; CARDIOVASCULAR AGENTS; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIUM; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 78649329262     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32833833a3     Document Type: Review

References (54)

1. WHO Expert Committee on problems related to alcohol consumption. World Health Organization Second Technical Report Series no. 944. Geneva: WHO; 2007.
2. Rehm J, Taylor B, Room R. Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev 2006; 25:503-513.
3. Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005; 365:51 9-530.
4. O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. JAm Coll Cardiol 2007; 50:1009-1914.
5. Di Castelnuovo A, Castanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women. Arch Intern Med2006; 166:2437-2445
6. ACC/AHA Task Force on Practice Guidelines. Manual for ACC/AHA. Guideline Writing Committees: methodologies and policies from the ACC/AHA Task Force on Practice Guidelines; 2006. Available at http://www.acc.org/qualityandscience/ clinical/manual/pdfs/methodology.Pdf and http://circ.ahajournals.org/manual/. [Accessed 30 January 2008].
7. Centers for Disease Control and Prevention. Vital and health statistics. Hyattsville, MD: US Department of Health and Human Services; October 1995. p. 13.
8. Alcohol and health: 10th Special Report to the U.S. Congress; effects of changes in alcoholprices and taxes. US Department of Health and Human Services, National Institutes of Health, NIAAA 2000.
9. Schaffert CS, Duryee MJ, Hunter CD, Hamilton BC 3rd, DeVeney AL, Huerter MM, et al. Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease. World J Gastroenterol 2009; 15:1209-1218.
10. Ramchandani VA, Bosron WF, Li TK. Research advances in ethanol metabolism. Pathol Biol (Paris) 2001; 49:676-682.
11. Vonghia L, Leggio L, Ferrulli A, Bertini M, Gasbarrini G, Addolorato G. Acute alcohol intoxication. Alcoholism Treatment Study Group. Eur J Intern Med 2008; 19:561-567.
12. Fernandez-Solà J, Preedy VR, Lang CH, Gonzalez-Reimers E, Arno M, Lin JC, et al. Molecular and cellular events in alcohol-induced muscle disease. Alcohol Clin Exp Res 2007; 31:1953-1962.
13. Hibbs RG, Ferrans VJ, Black WC, Weilbaecher DG, Burch GE. Alcoholic cardiomyopathy: an electron microscopy study. Am Heart J 1965; 69:766-779.
14. Chen DB, Wang L, Wang PH. Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes. Life Sci 2000; 67:1683-1693.
15. Jänkälä H, Eklund KK, Kokkonen JO, Kovanen PT, Linstedt KA, Härkönen M, Mäki T. Ethanol infusion increases ANP and p21 gene expression in isolated perfused rat heart. Biochem Biophys Res Commun 2001; 281:328-333.
16. Alexander CS. Electron microscopic observations in alcoholic heart muscle disease. Br Heart J 1967; 29:200-206.
17. Kim SD, Bieniarz T, Esser KA, Piano MR. Cardiac structure and function after short-term ethanol consumption in rats. Alcohol 2003; 29:21-29.
18. Meehan J, Piano MR, Solaro RJ. Heavy long-term ethanol consumption induces an alpha-to beta-myosin heavy chain isoforms transition in rat Basic Res Cardiol 1999; 94:481-488.
19. Preedy VR, Patel VB, Why HJ, Corbett JM, Dunn MJ, Richardon PJ. Alcohol and the heart: biochemical alterations. Cardiovasc Res 1996; 31:139-147.
20. Figueredo VM, Change KC, Baker AJ. Chronic alcohol induced changes in cardiaccontractilityare notduetochangesinthecytosolicCa2+transient. Am J Physiol Heart Circ Physiol 1998; 275:H122-H130.
21. Piano MR, Schwertz DW, Solaro RJ. Effect of pimobenden and isoproterenol in the alcoholic myocardium. J Cardiovasc Pharmacol1999; 33:237-242.
22. Wu S, White R, Eikman-Cofflet J, Sievers R, Wendland M. The preventive effectof verapamil on ethanol-induced cardiac depression: phosphorus-31 nuclear magnetic resonance and high-pressure liquid chromatography studies of hamsters. Circulation 1987; 75:1058-1064.
23. Adams MA, Hirst M. Metoprolol suppresses the development of ethanol-induced cardiac hypertrophy in the rat. Can J Physiol Pharmacol1990; 68:562-567.
24. Kim SD, Beck J, Bieniarz T, Schumacher A, Piano MR. A rodent model of alcoholic heart muscle disease and its evaluation by echocardiography. Alcohol Clin Exp Res 2110; 25:457-463.
25. Kostis JB, Mareyra AE, Amendo MT, Dipietro J, Cosgrove N, Kuo PT. The effect of age on heart rate in subjects free of heart disease. Studies by ambulatory electrocardiography and maximal exercise stress test. Circulation 1982; 65:141-145.
26. Reunanen A, Karjalainen R, Ristolia P, Heliovaara M, Knekt P, Aromaa A. Heart rate and mortality. J Intern Med 2000; 247:231-239.
27. Piano MR. Alcohol and heart failure. J Card Fail 2002; 8:239-246.
28. Urbano-Marquez A, Estruch R, Lopez FN, Grau JM, Mont L, Rubin E. The effects ofalcoholism on skelet al and cardiac muscle. N Engl J Med 1989; 320:409-415.
29. Djoussé L, Gaziano JM. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation 2007; 115:34-39. (Pubitemid 46058609)
30. Gavazzi A, De Maria R, Renosto G, Moro A, Borgia M, Caroli A, et al. The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. Am Heart J 1993; 125:410-422.
31. Askanas A, Udoshi M, Sadjadi SA. The heart in chronic alcoholism: a noninvasive study. Am Heart J 1980; 99:9-16.
32. Kino M, Imamitchi H, Morigutchi M, Kawamura K, Takatsu T. Cardiovascular status in asymptomatic alcoholics, with reference to the level of ethanol consumption. Br Heart J 1981; 46:545-551.
33. Kupari M, Koskinen P, Suokas A. Leftventricularsize, mass and function in relation to the duration and quantity of heavy drinking in alcoholics. Am J Cardiol1991; 67:274-279.
34. LazarevićAM, Nakatani S, Nesković AN, MarinkovićJ, Yasumura Y, Stojicić D, et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. JAm Coll Cardiol 2000; 35:1599-1606.
35. Fernández-Solà J, Nicolás JM, ParéJC, Sacanella E, Fatjó F, Cofán M, et al. Diastolic function impairment in alcoholics. Alcohol Clin Exp Res 2000; 24:1830-1835.
36. Fernández-Solà J, Nicolás JM, Oriola J, Sacanella E, Estruch R, Rubin E, et al. Angiotensin-converting enzyme gene polymorphism is associated with vulnerabilitytoalcoholic cardiomyopathy. Ann Intern Med 2002; 137:321-326.
37. De Maria R, Gavazzi A, Recalcati F, Baroldi G, De Vita C, Camerini F. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. Am J Cardiol 1993; 72:580-585.
38. Piano MR. Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest2002; 121:1638-1650.
39. Urbano-Marquez A, Estruch R, Fernandez-Sola J, Nicolas JM, Pare JC, Rubin E. The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA 1995; 274:149-154.
40. Fernández-Solà J, Estruch R, Nicolas JM, Pare JC, Sacanella E, Antunez E, et al. Comparison ofalcoholiccardiomyopathy in women versus men. Am J Cardiol1997; 80:481-485.
41. Prazak P, Pfisterer M, Osswald S, Buser P, Burkart F. Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy. Eur Heart J 1996; 17:251-257.
42. Gavazzi A, De Maria R, Parolini M, Porcu M. Alcohol abuse and cardiomyopathy in men. Am J Cardiol 2000; 85:1114-1118.
43. Fauchier L, Babuty D, Poret P, Casset-Senon D, Autret ML, Cosnay P, et al. Comparison of long term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J 2000; 2:306-314.
44. Ballester M, Mart́i V, Carrió I, Obrador D, Moya C, Pons-Lladó G, et al. Spectrum of alcohol-induced myocardial damage detected by indium-111-labeled monoclonal antimyosin antibodies. JAm Coll Cardiol1997; 29:160-167.
45. Nicolás JM, Fernández-Solà J, Estruch R, Paré JC, Sacanella E, Urbano-Márquez A, Rubin E. The effect of controlled drinking in alcoholic cardiomyopathy. Ann Intern Med 2002; 136:192-200.
46. Walsh CR, Larson MG, Evans JC, Djousse L, Ellison RC, Vasan RS, Levy D. Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2002; 136:181-191. (Pubitemid 34118118)
47. Abramson JL, Williams SA, Krumholz HM, Vaccarino V. Moderate alcohol consumption and risk of heart failure among older persons. JAMA 2001; 285:1971-1977. (Pubitemid 32366949)
48. Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. JAm Coll Cardiol 2000; 35:1753-1759.
49. Salisbury AC, House JA, Conard MW, Krumholz HM, Spertus JA. Low-to-moderate alcohol intake and health status in heart failure patients. J Card Fail 2005; 11:323-328.
50. Urbano-Márquez A, Fernández-Solà J. Alcohol consumption and heart failure. J Card Fail 2005; 11:323-328.
51. De Maria R, Di Lenarda A, Gavazzi A, Porcu M, Sinagra GF, Parolini M, on behalf of the SPIC (Italian Multicenter Cardiomyopathy Study) Group. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favourably influences outcome. It Heart J 2001; 2:130-138.
52. Fauchier L. Alcoholic cardiomyopathy and ventricular arrhythmias. Chest 2003; 123:1320.
53. The physician's guide to helping patients with alcohol problems. National Institutes of Health publication no. 95-3769. Washington DC: US Department of Health and Human Services: 1995.
54. Haissaguerre M, Fleury B, Gueguen A, Bonnet J, Lorente P, Nakache JP. Mortalité des myocardiopathies dilatèes en fonction de la poursuite de l'alcolisation. Presse Med 1989; 18:711-714.